| Previous close | 113.47 |
| Open | 113.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 111.22 - 115.02 |
| 52-week range | 74.71 - 138.89 |
| Volume | |
| Avg. volume | 2,732 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.22 |
| PE ratio (TTM) | 2.28 |
| EPS (TTM) | 0.49 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Calculating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, DexCom fair value estimate is US$113 DexCom's US$113 share...
Barrons.comDid Your Heart Just Skip a Beat? Your Watch Already Knows That and More.
Smart rings and smartwatches are providing consumers with reams of health information. Clinical device makers like DexCom needn’t worry.
Insider MonkeyWhy Is DexCom, Inc. (DXCM) One Of The Best Growth Stocks for Billionaire Ray Dalio?
We recently compiled a list of the 10 Best Growth Stocks To Buy Now According To Billionaire Ray Dalio. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other growth stocks. Ray Dalio is one of the most successful investors in Wall Street’s history. He has […]
© 2024 Yahoo. All rights reserved.